Literature DB >> 25037575

Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in Oral cancer.

Ravindran Gokulan1, Devaraj Halagowder.   

Abstract

Notch pathway molecules crosstalk with Wnt/β-catenin signaling cascade in stem cells and tumors. However, the correlation between the expression pattern of Notch intracellular domain NICD, Hes-1 and c-Myc has not been studied in oral squamous cell carcinoma. The aim of this study is to investigate the correlation and prognostic significance of NICD, Hes-1 and c-Myc in oral cancer. Immunohistochemistry was used to study the expression pattern of NICD, Hes-1 and c-Myc in oral preneoplastic and neoplastic tissues. In addition, double immunofluorescence was used to examine the co-localization of NICD, Hes-1 and c-Myc in H314 cells. The expression pattern of NICD and Hes-1 was gradually increased from normal to dysplasia to carcinoma. Interestingly, statistically significant correlation was not observed between NICD, Hes-1 and c-Myc in oral squamous cell carcinoma. Furthermore, NICD+/c-Myc+ and Hes-1+/c-Myc+ double positive cases showed worst survival when compared with other cases in oral cancer. Notch signaling molecules, NICD and Hes-1, are found to be involved in the progression of oral squamous cell carcinoma. Interestingly, NICD, Hes-1 and c-Myc may have independent roles in oral cancer. On the other hand, we have demonstrated that NICD+/c-Myc+ and Hes-1+/c-Myc+ double positivity might be used as independent prognostic indicator of oral carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25037575     DOI: 10.1007/s12032-014-0126-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  34 in total

1.  Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.

Authors:  Juntao Liu; Zhangfan Mao; Jie Huang; Songping Xie; Tianshu Liu; Zhifu Mao
Journal:  Biochem Biophys Res Commun       Date:  2014-02-03       Impact factor: 3.575

2.  Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer.

Authors:  Yiyu Dong; Aimin Li; Jianbo Wang; Jason D Weber; Loren S Michel
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

Review 3.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

4.  Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors.

Authors:  Ian Krop; Tim Demuth; Tina Guthrie; Patrick Y Wen; Warren P Mason; Prakash Chinnaiyan; Nicholas Butowski; Morris D Groves; Santosh Kesari; Steven J Freedman; Samuel Blackman; James Watters; Andrey Loboda; Alexei Podtelezhnikov; Jared Lunceford; Cong Chen; Maxine Giannotti; Jeremy Hing; Robert Beckman; Patricia Lorusso
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

5.  The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.

Authors:  Helena A Minter; John W Eveson; Suzanne Huntley; Douglas J E Elder; Angela Hague
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

6.  Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in squamous neoplasms.

Authors:  Kei Sakamoto; Takuma Fujii; Hiroshi Kawachi; Yoshio Miki; Ken Omura; Kei-ichi Morita; Kou Kayamori; Ken-ichi Katsube; Akira Yamaguchi
Journal:  Lab Invest       Date:  2012-02-13       Impact factor: 5.662

Review 7.  Synthetic lethality: general principles, utility and detection using genetic screens in human cells.

Authors:  Sebastian M B Nijman
Journal:  FEBS Lett       Date:  2010-11-19       Impact factor: 4.124

8.  Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.

Authors:  Grégory Peignon; Aurélie Durand; Wulfran Cacheux; Olivier Ayrault; Benoît Terris; Pierre Laurent-Puig; Noah F Shroyer; Isabelle Van Seuningen; Tasuku Honjo; Christine Perret; Béatrice Romagnolo
Journal:  Gut       Date:  2011-02       Impact factor: 23.059

9.  Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancers (Basel)       Date:  2011-02-21       Impact factor: 6.639

10.  Differential expression of Notch1 intracellular domain and p21 proteins, and their clinical significance in gastric cancer.

Authors:  Ding-Hai Luo; Qin Zhou; Sun-Kuan Hu; Yi-Qun Xia; Chao-Chao Xu; Tie-Su Lin; Yu-Ting Pan; Jian-Sheng Wu; Rong Jin
Journal:  Oncol Lett       Date:  2013-12-11       Impact factor: 2.967

View more
  7 in total

Review 1.  Notch as a tumour suppressor.

Authors:  Craig S Nowell; Freddy Radtke
Journal:  Nat Rev Cancer       Date:  2017-02-03       Impact factor: 60.716

2.  Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines.

Authors:  D M Nanayakkara; M N Nguyen; S A Wood
Journal:  Cell Prolif       Date:  2016-07-04       Impact factor: 6.831

Review 3.  The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.

Authors:  T Fukusumi; J A Califano
Journal:  J Dent Res       Date:  2018-02-28       Impact factor: 6.116

4.  Stem Cell Markers CXCR-4 and CD133 Predict Aggressive Phenotype and Their Double Positivity Indicates Poor Prognosis of Oral Squamous Cell Carcinoma.

Authors:  Ravindran Caspa Gokulan; Halagowder Devaraj
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

Review 5.  Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?

Authors:  Min Zhang; Sangita Biswas; Xin Qin; Wenrong Gong; Wenbing Deng; Hongjun Yu
Journal:  Cancer Med       Date:  2016-05-26       Impact factor: 4.452

6.  Notch Intracellular Domain (NICD) Expression and Clinical Manifestations of Second Primary Tumor at Esophagus in Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Tauangtham Anekpuritanang; Warut Pongsapich; Tanasarun Watcharadilokkul; Premyot Ngaotepprutaram; Paveena Pithuksurachai; Sacarin Bunbanjerdsuk
Journal:  Onco Targets Ther       Date:  2019-12-17       Impact factor: 4.147

7.  NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis.

Authors:  Vasiliki Salameti; Priyanka G Bhosale; Ashley Ames-Draycott; Kalle Sipilä; Fiona M Watt
Journal:  Oncotarget       Date:  2019-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.